nodes	percent_of_prediction	percent_of_DWPC	metapath
Nortriptyline—HTR2C—metabolic syndrome X	0.537	0.697	CbGaD
Nortriptyline—ALB—metabolic syndrome X	0.234	0.304	CbGaD
Nortriptyline—SLC6A2—sympathetic nervous system—metabolic syndrome X	0.00683	0.127	CbGeAlD
Nortriptyline—HTR2A—arteriole—metabolic syndrome X	0.00644	0.12	CbGeAlD
Nortriptyline—SLC6A2—autonomic nervous system—metabolic syndrome X	0.00459	0.0855	CbGeAlD
Nortriptyline—HTR2A—sympathetic nervous system—metabolic syndrome X	0.00411	0.0764	CbGeAlD
Nortriptyline—HTR2A—autonomic nervous system—metabolic syndrome X	0.00276	0.0514	CbGeAlD
Nortriptyline—PTGS1—artery—metabolic syndrome X	0.00173	0.0323	CbGeAlD
Nortriptyline—HTR2A—artery—metabolic syndrome X	0.00156	0.0291	CbGeAlD
Nortriptyline—Appetite absent—Metformin—metabolic syndrome X	0.00154	0.118	CcSEcCtD
Nortriptyline—PTGS1—endothelium—metabolic syndrome X	0.00147	0.0273	CbGeAlD
Nortriptyline—ADRA1B—kidney—metabolic syndrome X	0.00146	0.0273	CbGeAlD
Nortriptyline—PTGS1—blood vessel—metabolic syndrome X	0.00135	0.0251	CbGeAlD
Nortriptyline—HTR2A—endothelium—metabolic syndrome X	0.00132	0.0246	CbGeAlD
Nortriptyline—HTR2A—blood vessel—metabolic syndrome X	0.00122	0.0227	CbGeAlD
Nortriptyline—CHRM2—cardiovascular system—metabolic syndrome X	0.00112	0.0209	CbGeAlD
Nortriptyline—CHRM1—cardiovascular system—metabolic syndrome X	0.00102	0.0191	CbGeAlD
Nortriptyline—HTR1A—cardiovascular system—metabolic syndrome X	0.000912	0.017	CbGeAlD
Nortriptyline—CHRM3—kidney—metabolic syndrome X	0.000896	0.0167	CbGeAlD
Nortriptyline—ADRA1A—cardiovascular system—metabolic syndrome X	0.000841	0.0157	CbGeAlD
Nortriptyline—CHRM3—adipose tissue—metabolic syndrome X	0.000808	0.015	CbGeAlD
Nortriptyline—ORM1—liver—metabolic syndrome X	0.000746	0.0139	CbGeAlD
Nortriptyline—ADRA1A—adipose tissue—metabolic syndrome X	0.000742	0.0138	CbGeAlD
Nortriptyline—Maprotiline—HTR2C—metabolic syndrome X	0.000693	0.128	CrCbGaD
Nortriptyline—CYP2C9—cardiovascular system—metabolic syndrome X	0.00066	0.0123	CbGeAlD
Nortriptyline—CYP3A5—kidney—metabolic syndrome X	0.000656	0.0122	CbGeAlD
Nortriptyline—ALB—liver—metabolic syndrome X	0.000654	0.0122	CbGeAlD
Nortriptyline—CYP2E1—cardiovascular system—metabolic syndrome X	0.000626	0.0116	CbGeAlD
Nortriptyline—Cyproheptadine—HTR2C—metabolic syndrome X	0.000615	0.113	CrCbGaD
Nortriptyline—CYP2E1—kidney—metabolic syndrome X	0.000612	0.0114	CbGeAlD
Nortriptyline—PTGS1—cardiovascular system—metabolic syndrome X	0.000603	0.0112	CbGeAlD
Nortriptyline—CYP3A5—adipose tissue—metabolic syndrome X	0.000592	0.011	CbGeAlD
Nortriptyline—PTGS1—kidney—metabolic syndrome X	0.00059	0.011	CbGeAlD
Nortriptyline—HRH1—adipose tissue—metabolic syndrome X	0.000574	0.0107	CbGeAlD
Nortriptyline—HTR2A—cardiovascular system—metabolic syndrome X	0.000544	0.0101	CbGeAlD
Nortriptyline—HTR2A—kidney—metabolic syndrome X	0.000532	0.0099	CbGeAlD
Nortriptyline—PTGS1—adipose tissue—metabolic syndrome X	0.000531	0.00989	CbGeAlD
Nortriptyline—CYP2C19—liver—metabolic syndrome X	0.000527	0.0098	CbGeAlD
Nortriptyline—ADRA1A—liver—metabolic syndrome X	0.00052	0.00968	CbGeAlD
Nortriptyline—CYP3A4—kidney—metabolic syndrome X	0.000493	0.00917	CbGeAlD
Nortriptyline—CYP2D6—kidney—metabolic syndrome X	0.000485	0.00902	CbGeAlD
Nortriptyline—Atomoxetine—HTR2C—metabolic syndrome X	0.000477	0.0879	CrCbGaD
Nortriptyline—Sweating increased—Metformin—metabolic syndrome X	0.000467	0.0359	CcSEcCtD
Nortriptyline—Mianserin—HTR2C—metabolic syndrome X	0.000466	0.0859	CrCbGaD
Nortriptyline—CYP1A2—liver—metabolic syndrome X	0.00043	0.00801	CbGeAlD
Nortriptyline—Drowsiness—Metformin—metabolic syndrome X	0.000427	0.0329	CcSEcCtD
Nortriptyline—Clomipramine—HTR2C—metabolic syndrome X	0.000426	0.0786	CrCbGaD
Nortriptyline—Chlorprothixene—HTR2C—metabolic syndrome X	0.000424	0.0782	CrCbGaD
Nortriptyline—Neuropathy peripheral—Metformin—metabolic syndrome X	0.000419	0.0322	CcSEcCtD
Nortriptyline—CYP3A5—liver—metabolic syndrome X	0.000415	0.00772	CbGeAlD
Nortriptyline—CYP2C9—liver—metabolic syndrome X	0.000408	0.0076	CbGeAlD
Nortriptyline—Trimipramine—HTR2C—metabolic syndrome X	0.000392	0.0723	CrCbGaD
Nortriptyline—CYP2E1—liver—metabolic syndrome X	0.000387	0.0072	CbGeAlD
Nortriptyline—Hepatitis—Metformin—metabolic syndrome X	0.000384	0.0295	CcSEcCtD
Nortriptyline—Hypoaesthesia—Metformin—metabolic syndrome X	0.000382	0.0293	CcSEcCtD
Nortriptyline—Oedema peripheral—Metformin—metabolic syndrome X	0.000378	0.0291	CcSEcCtD
Nortriptyline—Doxepin—HTR2C—metabolic syndrome X	0.000374	0.0689	CrCbGaD
Nortriptyline—Eye disorder—Metformin—metabolic syndrome X	0.000359	0.0276	CcSEcCtD
Nortriptyline—Flushing—Metformin—metabolic syndrome X	0.000356	0.0274	CcSEcCtD
Nortriptyline—Desipramine—HTR2C—metabolic syndrome X	0.000343	0.0632	CrCbGaD
Nortriptyline—HTR2A—liver—metabolic syndrome X	0.000336	0.00626	CbGeAlD
Nortriptyline—Dysgeusia—Metformin—metabolic syndrome X	0.000327	0.0251	CcSEcCtD
Nortriptyline—Oxcarbazepine—ALB—metabolic syndrome X	0.000323	0.0596	CrCbGaD
Nortriptyline—Vision blurred—Metformin—metabolic syndrome X	0.000315	0.0242	CcSEcCtD
Nortriptyline—Tremor—Metformin—metabolic syndrome X	0.000313	0.0241	CcSEcCtD
Nortriptyline—CYP3A4—liver—metabolic syndrome X	0.000311	0.00579	CbGeAlD
Nortriptyline—Ill-defined disorder—Metformin—metabolic syndrome X	0.00031	0.0238	CcSEcCtD
Nortriptyline—CYP2D6—liver—metabolic syndrome X	0.000306	0.0057	CbGeAlD
Nortriptyline—Malaise—Metformin—metabolic syndrome X	0.000301	0.0232	CcSEcCtD
Nortriptyline—Syncope—Metformin—metabolic syndrome X	0.0003	0.023	CcSEcCtD
Nortriptyline—Palpitations—Metformin—metabolic syndrome X	0.000295	0.0227	CcSEcCtD
Nortriptyline—Loss of consciousness—Metformin—metabolic syndrome X	0.000294	0.0226	CcSEcCtD
Nortriptyline—Imipramine—HTR2C—metabolic syndrome X	0.000291	0.0536	CrCbGaD
Nortriptyline—Amitriptyline—HTR2C—metabolic syndrome X	0.000289	0.0533	CrCbGaD
Nortriptyline—Hypertension—Metformin—metabolic syndrome X	0.000288	0.0222	CcSEcCtD
Nortriptyline—Discomfort—Metformin—metabolic syndrome X	0.000281	0.0216	CcSEcCtD
Nortriptyline—Oedema—Metformin—metabolic syndrome X	0.000273	0.021	CcSEcCtD
Nortriptyline—Shock—Metformin—metabolic syndrome X	0.000268	0.0206	CcSEcCtD
Nortriptyline—Thrombocytopenia—Metformin—metabolic syndrome X	0.000267	0.0205	CcSEcCtD
Nortriptyline—Hyperhidrosis—Metformin—metabolic syndrome X	0.000264	0.0203	CcSEcCtD
Nortriptyline—Anorexia—Metformin—metabolic syndrome X	0.00026	0.02	CcSEcCtD
Nortriptyline—Hypotension—Metformin—metabolic syndrome X	0.000255	0.0196	CcSEcCtD
Nortriptyline—Paraesthesia—Metformin—metabolic syndrome X	0.000245	0.0188	CcSEcCtD
Nortriptyline—Somnolence—Metformin—metabolic syndrome X	0.000242	0.0186	CcSEcCtD
Nortriptyline—Dyspepsia—Metformin—metabolic syndrome X	0.00024	0.0184	CcSEcCtD
Nortriptyline—Decreased appetite—Metformin—metabolic syndrome X	0.000237	0.0182	CcSEcCtD
Nortriptyline—Fatigue—Metformin—metabolic syndrome X	0.000235	0.0181	CcSEcCtD
Nortriptyline—Constipation—Metformin—metabolic syndrome X	0.000233	0.0179	CcSEcCtD
Nortriptyline—Feeling abnormal—Metformin—metabolic syndrome X	0.000225	0.0173	CcSEcCtD
Nortriptyline—Urticaria—Metformin—metabolic syndrome X	0.000217	0.0166	CcSEcCtD
Nortriptyline—Abdominal pain—Metformin—metabolic syndrome X	0.000215	0.0166	CcSEcCtD
Nortriptyline—Asthenia—Metformin—metabolic syndrome X	0.000196	0.015	CcSEcCtD
Nortriptyline—Pruritus—Metformin—metabolic syndrome X	0.000193	0.0148	CcSEcCtD
Nortriptyline—Diarrhoea—Metformin—metabolic syndrome X	0.000186	0.0143	CcSEcCtD
Nortriptyline—Clomipramine—ALB—metabolic syndrome X	0.000186	0.0342	CrCbGaD
Nortriptyline—Dizziness—Metformin—metabolic syndrome X	0.00018	0.0139	CcSEcCtD
Nortriptyline—Vomiting—Metformin—metabolic syndrome X	0.000173	0.0133	CcSEcCtD
Nortriptyline—Rash—Metformin—metabolic syndrome X	0.000172	0.0132	CcSEcCtD
Nortriptyline—Dermatitis—Metformin—metabolic syndrome X	0.000172	0.0132	CcSEcCtD
Nortriptyline—Headache—Metformin—metabolic syndrome X	0.000171	0.0131	CcSEcCtD
Nortriptyline—Nausea—Metformin—metabolic syndrome X	0.000162	0.0124	CcSEcCtD
Nortriptyline—Amitriptyline—ALB—metabolic syndrome X	0.000126	0.0232	CrCbGaD
Nortriptyline—HTR1A—Signaling Pathways—IGF1—metabolic syndrome X	9.86e-06	6.31e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—IGF1—metabolic syndrome X	9.81e-06	6.27e-05	CbGpPWpGaD
Nortriptyline—CHRM4—GPCR downstream signaling—AKT1—metabolic syndrome X	9.76e-06	6.24e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—INS—metabolic syndrome X	9.71e-06	6.21e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—PLA2G4A—metabolic syndrome X	9.66e-06	6.18e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling by GPCR—IL6—metabolic syndrome X	9.61e-06	6.15e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Metabolism—ALB—metabolic syndrome X	9.57e-06	6.12e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—CCL2—metabolic syndrome X	9.55e-06	6.11e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	9.52e-06	6.09e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—LPL—metabolic syndrome X	9.48e-06	6.06e-05	CbGpPWpGaD
Nortriptyline—PTGS1—Metabolism—PTGS2—metabolic syndrome X	9.44e-06	6.04e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—SLC2A4—metabolic syndrome X	9.41e-06	6.02e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—ABCA1—metabolic syndrome X	9.41e-06	6.02e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—NAMPT—metabolic syndrome X	9.4e-06	6.01e-05	CbGpPWpGaD
Nortriptyline—HTR6—Signaling by GPCR—AKT1—metabolic syndrome X	9.4e-06	6.01e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—IGF1—metabolic syndrome X	9.39e-06	6.01e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—SERPINE1—metabolic syndrome X	9.36e-06	5.99e-05	CbGpPWpGaD
Nortriptyline—CHRM5—GPCR downstream signaling—AKT1—metabolic syndrome X	9.35e-06	5.98e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—IRS1—metabolic syndrome X	9.34e-06	5.98e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—GCK—metabolic syndrome X	9.34e-06	5.98e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—LIPC—metabolic syndrome X	9.34e-06	5.98e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—PPARA—metabolic syndrome X	9.33e-06	5.97e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—SERPINE1—metabolic syndrome X	9.31e-06	5.96e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—APOC3—metabolic syndrome X	9.28e-06	5.94e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling by GPCR—IL6—metabolic syndrome X	9.2e-06	5.89e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—IRS1—metabolic syndrome X	9.19e-06	5.88e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—IRS1—metabolic syndrome X	9.17e-06	5.87e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Metabolism—NOS3—metabolic syndrome X	9.16e-06	5.86e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—IRS1—metabolic syndrome X	9.15e-06	5.85e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—APOB—metabolic syndrome X	9.13e-06	5.84e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—IRS1—metabolic syndrome X	9.12e-06	5.83e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—GOT1—metabolic syndrome X	9.11e-06	5.83e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—GGT1—metabolic syndrome X	9.11e-06	5.83e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—APOB—metabolic syndrome X	9.05e-06	5.79e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—AGT—metabolic syndrome X	9.03e-06	5.78e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—IRS1—metabolic syndrome X	9.03e-06	5.78e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—CETP—metabolic syndrome X	9.01e-06	5.76e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—CD36—metabolic syndrome X	9.01e-06	5.76e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—IRS1—metabolic syndrome X	9e-06	5.76e-05	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—PPARG—metabolic syndrome X	8.97e-06	5.74e-05	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—PPARG—metabolic syndrome X	8.95e-06	5.73e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—INS—metabolic syndrome X	8.95e-06	5.72e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—NOS3—metabolic syndrome X	8.94e-06	5.72e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—SERPINE1—metabolic syndrome X	8.92e-06	5.7e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—NOS3—metabolic syndrome X	8.89e-06	5.69e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—PLA2G4A—metabolic syndrome X	8.88e-06	5.68e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling by GPCR—AKT1—metabolic syndrome X	8.86e-06	5.67e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—APOE—metabolic syndrome X	8.85e-06	5.66e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—INS—metabolic syndrome X	8.8e-06	5.63e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—PLA2G4A—metabolic syndrome X	8.8e-06	5.63e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—CCL2—metabolic syndrome X	8.8e-06	5.63e-05	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—INS—metabolic syndrome X	8.8e-06	5.63e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—GPCR downstream signaling—AKT1—metabolic syndrome X	8.79e-06	5.62e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—INS—metabolic syndrome X	8.79e-06	5.62e-05	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—INS—metabolic syndrome X	8.78e-06	5.62e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—INS—metabolic syndrome X	8.76e-06	5.6e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—APOA1—metabolic syndrome X	8.75e-06	5.6e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—INS—metabolic syndrome X	8.73e-06	5.59e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—LPL—metabolic syndrome X	8.72e-06	5.58e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—CCL2—metabolic syndrome X	8.66e-06	5.54e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—IGF1—metabolic syndrome X	8.66e-06	5.54e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling by GPCR—IL6—metabolic syndrome X	8.65e-06	5.53e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—INS—metabolic syndrome X	8.65e-06	5.53e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—CCL2—metabolic syndrome X	8.64e-06	5.53e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—LPL—metabolic syndrome X	8.64e-06	5.53e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—SCARB1—metabolic syndrome X	8.63e-06	5.52e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—INS—metabolic syndrome X	8.62e-06	5.52e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—CCL2—metabolic syndrome X	8.62e-06	5.51e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—CCL2—metabolic syndrome X	8.59e-06	5.5e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—IGF1—metabolic syndrome X	8.52e-06	5.45e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—NOS3—metabolic syndrome X	8.51e-06	5.45e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—CCL2—metabolic syndrome X	8.51e-06	5.44e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—IGF1—metabolic syndrome X	8.5e-06	5.44e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling by GPCR—AKT1—metabolic syndrome X	8.49e-06	5.43e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—CCL2—metabolic syndrome X	8.48e-06	5.43e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—IGF1—metabolic syndrome X	8.47e-06	5.42e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—IGF1—metabolic syndrome X	8.44e-06	5.4e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—SREBF1—metabolic syndrome X	8.38e-06	5.36e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Metabolism—PTGS2—metabolic syndrome X	8.37e-06	5.36e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—PPARA—metabolic syndrome X	8.37e-06	5.36e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—IGF1—metabolic syndrome X	8.36e-06	5.35e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—IGF1—metabolic syndrome X	8.34e-06	5.34e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—CD36—metabolic syndrome X	8.28e-06	5.3e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—SERPINE1—metabolic syndrome X	8.22e-06	5.26e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—CD36—metabolic syndrome X	8.21e-06	5.25e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—GOT2—metabolic syndrome X	8.15e-06	5.21e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—HMGCR—metabolic syndrome X	8.15e-06	5.21e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—AGT—metabolic syndrome X	8.11e-06	5.19e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—SERPINE1—metabolic syndrome X	8.09e-06	5.17e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—SERPINE1—metabolic syndrome X	8.07e-06	5.16e-05	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—ALB—metabolic syndrome X	8.07e-06	5.16e-05	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—ALB—metabolic syndrome X	8.05e-06	5.15e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—SERPINE1—metabolic syndrome X	8.04e-06	5.15e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—SERPINE1—metabolic syndrome X	8.02e-06	5.13e-05	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—TGFB1—metabolic syndrome X	7.98e-06	5.11e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling by GPCR—AKT1—metabolic syndrome X	7.98e-06	5.11e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—APOE—metabolic syndrome X	7.94e-06	5.08e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—SERPINE1—metabolic syndrome X	7.94e-06	5.08e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—SERPINE1—metabolic syndrome X	7.92e-06	5.07e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—APOA1—metabolic syndrome X	7.85e-06	5.02e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—NOS3—metabolic syndrome X	7.85e-06	5.02e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—APOB—metabolic syndrome X	7.73e-06	4.95e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—NOS3—metabolic syndrome X	7.72e-06	4.94e-05	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—NOS3—metabolic syndrome X	7.71e-06	4.94e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—PPARG—metabolic syndrome X	7.71e-06	4.93e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—NOS3—metabolic syndrome X	7.7e-06	4.93e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—PPARA—metabolic syndrome X	7.7e-06	4.93e-05	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—NOS3—metabolic syndrome X	7.7e-06	4.93e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—NOS3—metabolic syndrome X	7.68e-06	4.91e-05	CbGpPWpGaD
Nortriptyline—HTR1A—GPCR downstream signaling—AKT1—metabolic syndrome X	7.66e-06	4.9e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—NOS3—metabolic syndrome X	7.66e-06	4.9e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—PPARA—metabolic syndrome X	7.63e-06	4.88e-05	CbGpPWpGaD
Nortriptyline—HTR2C—GPCR downstream signaling—AKT1—metabolic syndrome X	7.62e-06	4.87e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—NOS3—metabolic syndrome X	7.58e-06	4.85e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—INS—metabolic syndrome X	7.56e-06	4.84e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—NOS3—metabolic syndrome X	7.56e-06	4.84e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling by GPCR—IL6—metabolic syndrome X	7.54e-06	4.82e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—TGFB1—metabolic syndrome X	7.53e-06	4.82e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—PLA2G4A—metabolic syndrome X	7.52e-06	4.81e-05	CbGpPWpGaD
Nortriptyline—ALB—Hemostasis—AKT1—metabolic syndrome X	7.52e-06	4.81e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling by GPCR—IL6—metabolic syndrome X	7.5e-06	4.8e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—AGT—metabolic syndrome X	7.46e-06	4.77e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—AGT—metabolic syndrome X	7.39e-06	4.73e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—LPL—metabolic syndrome X	7.39e-06	4.72e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—APOE—metabolic syndrome X	7.31e-06	4.67e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—GPCR downstream signaling—AKT1—metabolic syndrome X	7.29e-06	4.67e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—ABCA1—metabolic syndrome X	7.26e-06	4.65e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—SLC2A4—metabolic syndrome X	7.26e-06	4.65e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—APOE—metabolic syndrome X	7.24e-06	4.63e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—APOA1—metabolic syndrome X	7.22e-06	4.62e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—TGFB1—metabolic syndrome X	7.21e-06	4.61e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling by GPCR—IL6—metabolic syndrome X	7.18e-06	4.59e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—APOA1—metabolic syndrome X	7.16e-06	4.58e-05	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—PTGS2—metabolic syndrome X	7.06e-06	4.51e-05	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—PTGS2—metabolic syndrome X	7.04e-06	4.5e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—GGT1—metabolic syndrome X	7.03e-06	4.5e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—GOT1—metabolic syndrome X	7.03e-06	4.5e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—CD36—metabolic syndrome X	7.02e-06	4.49e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling by GPCR—AKT1—metabolic syndrome X	6.95e-06	4.45e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—PPARG—metabolic syndrome X	6.92e-06	4.43e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling by GPCR—AKT1—metabolic syndrome X	6.92e-06	4.43e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—INS—metabolic syndrome X	6.79e-06	4.34e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—TGFB1—metabolic syndrome X	6.78e-06	4.34e-05	CbGpPWpGaD
Nortriptyline—DRD2—GPCR downstream signaling—AKT1—metabolic syndrome X	6.72e-06	4.3e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—NOS3—metabolic syndrome X	6.63e-06	4.24e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling by GPCR—AKT1—metabolic syndrome X	6.62e-06	4.24e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling by GPCR—IL6—metabolic syndrome X	6.62e-06	4.23e-05	CbGpPWpGaD
Nortriptyline—HTR2A—GPCR downstream signaling—AKT1—metabolic syndrome X	6.62e-06	4.23e-05	CbGpPWpGaD
Nortriptyline—HRH1—GPCR downstream signaling—AKT1—metabolic syndrome X	6.6e-06	4.22e-05	CbGpPWpGaD
Nortriptyline—CHRM1—GPCR downstream signaling—AKT1—metabolic syndrome X	6.58e-06	4.21e-05	CbGpPWpGaD
Nortriptyline—CHRM3—GPCR downstream signaling—AKT1—metabolic syndrome X	6.56e-06	4.2e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—PPARA—metabolic syndrome X	6.52e-06	4.17e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling by GPCR—IL6—metabolic syndrome X	6.51e-06	4.17e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling by GPCR—IL6—metabolic syndrome X	6.5e-06	4.16e-05	CbGpPWpGaD
Nortriptyline—CHRM2—GPCR downstream signaling—AKT1—metabolic syndrome X	6.5e-06	4.16e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—GPCR downstream signaling—AKT1—metabolic syndrome X	6.48e-06	4.14e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling by GPCR—IL6—metabolic syndrome X	6.48e-06	4.14e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling by GPCR—IL6—metabolic syndrome X	6.46e-06	4.13e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling by GPCR—IL6—metabolic syndrome X	6.39e-06	4.09e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling by GPCR—IL6—metabolic syndrome X	6.38e-06	4.08e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—PPARG—metabolic syndrome X	6.36e-06	4.07e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—AGT—metabolic syndrome X	6.32e-06	4.04e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—PPARG—metabolic syndrome X	6.31e-06	4.04e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—INS—metabolic syndrome X	6.24e-06	3.99e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—ALB—metabolic syndrome X	6.22e-06	3.98e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—APOE—metabolic syndrome X	6.19e-06	3.96e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—INS—metabolic syndrome X	6.19e-06	3.96e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—APOA1—metabolic syndrome X	6.12e-06	3.91e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling by GPCR—AKT1—metabolic syndrome X	6.11e-06	3.91e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—PTGS2—metabolic syndrome X	6.06e-06	3.88e-05	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—IL6—metabolic syndrome X	6.02e-06	3.85e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling by GPCR—AKT1—metabolic syndrome X	6.01e-06	3.84e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling by GPCR—AKT1—metabolic syndrome X	6e-06	3.84e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling by GPCR—AKT1—metabolic syndrome X	5.98e-06	3.82e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—APOB—metabolic syndrome X	5.97e-06	3.82e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling by GPCR—AKT1—metabolic syndrome X	5.96e-06	3.81e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—NOS3—metabolic syndrome X	5.95e-06	3.81e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—TGFB1—metabolic syndrome X	5.91e-06	3.78e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling by GPCR—AKT1—metabolic syndrome X	5.9e-06	3.77e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling by GPCR—AKT1—metabolic syndrome X	5.88e-06	3.76e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—TGFB1—metabolic syndrome X	5.88e-06	3.76e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—PLA2G4A—metabolic syndrome X	5.81e-06	3.71e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—ALB—metabolic syndrome X	5.72e-06	3.66e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—LPL—metabolic syndrome X	5.7e-06	3.65e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—IL6—metabolic syndrome X	5.68e-06	3.63e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—ALB—metabolic syndrome X	5.67e-06	3.63e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—TGFB1—metabolic syndrome X	5.63e-06	3.6e-05	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—AKT1—metabolic syndrome X	5.55e-06	3.55e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—NOS3—metabolic syndrome X	5.47e-06	3.5e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—PTGS2—metabolic syndrome X	5.44e-06	3.48e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—IL6—metabolic syndrome X	5.43e-06	3.48e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—NOS3—metabolic syndrome X	5.43e-06	3.47e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—CD36—metabolic syndrome X	5.42e-06	3.46e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—PPARG—metabolic syndrome X	5.39e-06	3.45e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—INS—metabolic syndrome X	5.29e-06	3.38e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—AKT1—metabolic syndrome X	5.24e-06	3.35e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—TGFB1—metabolic syndrome X	5.19e-06	3.32e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—IL6—metabolic syndrome X	5.11e-06	3.27e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—TGFB1—metabolic syndrome X	5.11e-06	3.27e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—TGFB1—metabolic syndrome X	5.09e-06	3.26e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—TGFB1—metabolic syndrome X	5.08e-06	3.25e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—TGFB1—metabolic syndrome X	5.06e-06	3.24e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—PPARA—metabolic syndrome X	5.03e-06	3.22e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—AKT1—metabolic syndrome X	5.01e-06	3.21e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—TGFB1—metabolic syndrome X	5.01e-06	3.21e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—PTGS2—metabolic syndrome X	5.01e-06	3.2e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—TGFB1—metabolic syndrome X	5e-06	3.2e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—PTGS2—metabolic syndrome X	4.96e-06	3.18e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—AGT—metabolic syndrome X	4.88e-06	3.12e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—ALB—metabolic syndrome X	4.85e-06	3.1e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—APOE—metabolic syndrome X	4.78e-06	3.06e-05	CbGpPWpGaD
Nortriptyline—PTGS1—Metabolism—AKT1—metabolic syndrome X	4.75e-06	3.04e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—APOA1—metabolic syndrome X	4.72e-06	3.02e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—AKT1—metabolic syndrome X	4.71e-06	3.02e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—NOS3—metabolic syndrome X	4.64e-06	2.97e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—IL6—metabolic syndrome X	4.45e-06	2.85e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—IL6—metabolic syndrome X	4.43e-06	2.83e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—PTGS2—metabolic syndrome X	4.24e-06	2.71e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—IL6—metabolic syndrome X	4.24e-06	2.71e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Metabolism—AKT1—metabolic syndrome X	4.21e-06	2.69e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—PPARG—metabolic syndrome X	4.16e-06	2.66e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—AKT1—metabolic syndrome X	4.11e-06	2.63e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—AKT1—metabolic syndrome X	4.09e-06	2.61e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—INS—metabolic syndrome X	4.08e-06	2.61e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—AKT1—metabolic syndrome X	3.91e-06	2.5e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—IL6—metabolic syndrome X	3.91e-06	2.5e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—IL6—metabolic syndrome X	3.85e-06	2.46e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—IL6—metabolic syndrome X	3.84e-06	2.46e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—IL6—metabolic syndrome X	3.83e-06	2.45e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—IL6—metabolic syndrome X	3.81e-06	2.44e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—IL6—metabolic syndrome X	3.78e-06	2.42e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—IL6—metabolic syndrome X	3.77e-06	2.41e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—ALB—metabolic syndrome X	3.74e-06	2.39e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—AKT1—metabolic syndrome X	3.61e-06	2.31e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—NOS3—metabolic syndrome X	3.58e-06	2.29e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—AKT1—metabolic syndrome X	3.55e-06	2.27e-05	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—AKT1—metabolic syndrome X	3.55e-06	2.27e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—AKT1—metabolic syndrome X	3.54e-06	2.27e-05	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—AKT1—metabolic syndrome X	3.54e-06	2.26e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—AKT1—metabolic syndrome X	3.53e-06	2.26e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—AKT1—metabolic syndrome X	3.52e-06	2.25e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—AKT1—metabolic syndrome X	3.48e-06	2.23e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—AKT1—metabolic syndrome X	3.48e-06	2.22e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—PTGS2—metabolic syndrome X	3.27e-06	2.09e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—AKT1—metabolic syndrome X	3.05e-06	1.95e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—AKT1—metabolic syndrome X	2.74e-06	1.75e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—AKT1—metabolic syndrome X	2.52e-06	1.61e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—AKT1—metabolic syndrome X	2.49e-06	1.6e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—AKT1—metabolic syndrome X	2.13e-06	1.36e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—AKT1—metabolic syndrome X	1.65e-06	1.05e-05	CbGpPWpGaD
